XULTOPHY
100U/ML+3,6MG/ML INJ SOL 1X3ML
| SÚKL code | 0210189 |
|---|---|
| Name of the product | XULTOPHY |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | XULTOPHY |
| Supplement | 100U/ML+3,6MG/ML INJ SOL 1X3ML |
| Strenght | 100U/ML+3,6MG/ML |
| Pharmaceutical form | Solution for injection |
| Package | 1X3ML |
| Route | Subcutaneous use |
| Wrap type | Pre-filled pen |
| Legal status | na lékařský předpis |
| Active substance |
LIRAGLUTIDE (LIRAGLUTIDUM) INSULIN DEGLUDEC (INSULINUM DEGLUDECUM) |
| ATC group | A10AE56 |
| ATC group name | INSULIN DEGLUDEK A LIRAGLUTID |
| Doping | Antagonisté a modulátory hormonů (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
| Registration Number | EU/1/14/947/001 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Novo Nordisk A/S, Bagsvaerd |
| MA Holder country | DÁNSKO |
cz